Literature DB >> 1483705

Genetic studies of antithrombin III with IEF and ASO hybridization.

C Dürr1, A Hinney, C Luckenbach, J Kömpf, H Ritter.   

Abstract

Antithrombin III (AT III) was analyzed by two different methods. Isoelectric focusing was used to screen 3 different populations (southwest Germans, Portuguese, Xavante Indians). The same variant was detected both in the German and the Portuguese populations with frequencies of 0.007 and 0.00024, respectively. Further characterization of this variant was performed by allele specific oligonucleotides. By this means, it was possible to identify the variant as AT III Dublin, originally found in 4 Irish families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483705     DOI: 10.1007/bf00220477

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

Review 1.  Antithrombin III.

Authors:  C H Beresford; M C Owen
Journal:  Int J Biochem       Date:  1990

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 3.  Molecular genetics of inherited antithrombin III deficiencies.

Authors:  E V Prochownik
Journal:  Am J Med       Date:  1989-09-11       Impact factor: 4.965

4.  Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.

Authors:  S C Bock; J A Marrinan; E Radziejewska
Journal:  Biochemistry       Date:  1988-08-09       Impact factor: 3.162

5.  Identification and characterization of a new antithrombin III familial variant (AT Dublin) with possible increased frequency in children with cancer.

Authors:  M Daly; A O'Meara; F M Hallinan
Journal:  Br J Haematol       Date:  1987-04       Impact factor: 6.998

6.  Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.

Authors:  M Daly; D Bruce; D J Perry; J Price; P L Harper; A O'Meara; R W Carrell
Journal:  FEBS Lett       Date:  1990-10-29       Impact factor: 4.124

Review 7.  Antithrombin: structure, genomic organization, function and inherited deficiency.

Authors:  D A Lane; R Caso
Journal:  Baillieres Clin Haematol       Date:  1989-10

8.  Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.

Authors:  P Molho-Sabatier; M Aiach; I Gaillard; J N Fiessinger; A M Fischer; G Chadeuf; E Clauser
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.